NBP NovaBridge Biosciences

NASDAQ
$1.96

NovaBridge Biosciences (NBP) is confirmed to report earnings on August 20, 2026, before the market open. The consensus earnings estimate is a loss of $0.14 per share.

Earnings Date
2nd Quarter, Jun 2026
Aug 20
Thursday · Before Open
Earnings Whisper
-
vs ($0.14)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NovaBridge Biosciences

NovaBridge Biosciences is a global biotechnology company advancing a portfolio of therapeutic programs in oncology and ophthalmology

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow